| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.81M | - | |
| VP | 79.5K | $725.1K | - | |
| VP | 67.4K | $614.6K | - | |
| VP | 65.1K | $593.5K | - | |
| VP | 56.3K | $513.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2015 | Mirza Mansoor Raza79 | Director | Sale+OE | 15,000 | $15.01 | $225,136.50 | -63.8% | |
| Apr 7, 2015 | Frenkel Ran78 | EVP, Ww Development Operations | Buy | 3,000 | $31.81 | $95,430.00 | +300.0% | |
| Apr 2, 2015 | Renz Justin A54 | EVP, CFO &Treasurer | Buy | 5,000 | $29.71 | $148,557.00 | New | |
| Apr 2, 2015 | Greene Barry E | Director | Buy | 3,000 | $29.31 | $87,938.40 | New | |
| Jan 12, 2015 | Shacham Sharon79 | President &CSO | Sell | 50,000 | $33.00 | $1,650,000.00 | -3.6% | |
| Jan 12, 2015 | Kauffman Michael78 | Chief Executive Officer | Sell | 50,000 | $33.00 | $1,650,000.00 | -3.6% | |
| Jan 12, 2015 | Pakianathan Deepika90 | Director | Buy | 45,454 | $33.00 | $1,499,982.00 | +2.0% |